The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETG.L Regulatory News (JETG)

  • There is currently no data for JETG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Restructuring and Amendments to Listing

3 Feb 2022 14:57

RNS Number : 6525A
JPMorgan European Invest Tst PLC
03 February 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL.

 

Legal Entity Identifier: 549300D8SPJFHBDGXS57

 

 

3 February 2022

 

JPMorgan European Investment Trust plc

Results of Restructuring and Amendments to Listing

Results of Restructuring

The Board of JPMorgan European Investment Trust plc (the "Company") is pleased to announce that, as a result of the Restructuring, conditional upon and with effect from Admission (as defined below) the Company's Growth Shares and Income Shares will be reorganised and redesignated as 437,420,913 Ordinary Shares of 0.5 pence nominal value each with an NAV per Share of 100p each calculated as at the Calculation Date (as defined below).

Pursuant to the Restructuring every 2.56076700 Growth Shares and every 2.90576038 Income Shares will, with effect from Admission, be consolidated into, respectively, one Consolidated Growth Shares and one Consolidated Income Share.

Based on the NAV per Growth Share and the NAV per Income Share as at 31 January 2022 (the "Calculation Date"), being 403.95 pence and 172.49 pence, each Consolidated Growth Share and each Consolidated Income Share be immediately subdivided into, respectively:

· 10.34425608 Resulting Growth Shares; and

· 5.01205895 Resulting Income Shares,

with each Resulting Growth Share and each Resulting Income Share having an NAV per Share of 100 pence as determined by reference to the above mentioned NAVs as at the Calculation Date.

All of the Resulting Growth Shares (290,075,314 in aggregate) and all of the Resulting Income Shares (147,345,599 in aggregate) be immediately redesignated as Ordinary Shares of 0.5 pence nominal (437,420,913 in aggregate).

In accordance with the Restructuring proposals the Deferred Shares that will as part of the process be repurchased by the Company immediately upon their creation out of its distributable reserves for the aggregate consideration of £1.00 and immediately cancelled.

Amendments to Listing

The Company has made applications to the FCA and to the LSE to amend their records with effect from 8:00 a.m. on 4 February 2022 ("Admission"):

1. To update the listing of the Growth Shares so as to retain a premium equity closed ended investment fund listing on the Official List and to continue trading on the premium segment of the LSE's main market, but to redesignate them as Ordinary Shares of 0.5 pence nominal, having the following details:

ISIN: GB00BPR9Y246SEDOL: BPR9Y24

2. To adjust the number of Ordinary Shares in issue to reflect the 437,420,913 Ordinary Shares that resulted in aggregate from the Restructuring process (290,075,314 in respect of the consolidation, sub-division and redesignation of Growth Shares and 147,345,599 in respect of the consolidation, sub-division and redesignation of Income Shares).

 

 

Change of name and ticker

Having received final approval from Companies House, the Company's name has been changed to JPMorgan European Growth & Income plc. The new name will apply to the Ordinary Shares with effect from Admission and the Ordinary Shares will also trade under a new ticker, JEGI.

Total voting rights

With effect from Admission the Company will have 437,420,913 Ordinary Shares in issue, each having one voting right. Accordingly, the total number of voting rights in the Company will be 437,420,913. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Company will also liaise with the FCA and the LSE to seek the removal of the Income Share security from the Official List and from trading on the LSE's main market as there are no longer any such shares in issue.

Full details of the Restructuring can be found in the circular published by the Company on 20 December 2021 (the "Circular") which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and from the Company's website, www.jpmeuropean.co.uk.

Terms used and not defined in this announcement shall have the meanings given to them in the Circular.

 

For further information please contact:

 

JPMorgan Funds Limited

Tim Mitchell - 0207 742 8879

Paul Winship - 0207 742 9815

 

Winterflood Securities Limited

Neil Morgan - 020 3100 0292

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTJMITMTAMBFT
Date   Source Headline
3rd Feb 20226:00 pmRNSJPMorgan European Investment Trust
3rd Feb 20222:57 pmRNSResults of Restructuring and Amendments to Listing
1st Feb 202211:25 amRNSNet Asset Value(s)
1st Feb 20229:19 amRNSTotal Voting Rights
31st Jan 202212:13 pmRNSGearing Announcement
31st Jan 202211:54 amRNSNet Asset Value(s)
28th Jan 202211:49 amRNSNet Asset Value(s)
27th Jan 202211:20 amRNSNet Asset Value(s)
26th Jan 202212:01 pmRNSNet Asset Value(s)
25th Jan 202211:58 amRNSNet Asset Value(s)
24th Jan 20221:52 pmRNSGearing Announcement
24th Jan 20221:01 pmRNSNet Asset Value(s)
24th Jan 202212:35 pmRNSResults of Meetings and Transaction Update
21st Jan 202212:28 pmRNSNet Asset Value(s)
20th Jan 202212:12 pmRNSNet Asset Value(s)
19th Jan 202211:45 amRNSNet Asset Value(s)
18th Jan 202211:06 amRNSNet Asset Value(s)
17th Jan 20224:59 pmRNSTransaction in Own Shares
17th Jan 202212:42 pmRNSTen Largest Investments
17th Jan 202211:51 amRNSGearing Announcement
17th Jan 202211:45 amRNSNet Asset Value(s)
14th Jan 202211:17 amRNSNet Asset Value(s)
13th Jan 202210:52 amRNSNet Asset Value(s)
12th Jan 20225:27 pmRNSTransaction in Own Shares
12th Jan 202210:39 amRNSNet Asset Value(s)
11th Jan 202210:58 amRNSNet Asset Value(s)
10th Jan 202211:46 amRNSGearing Announcement
10th Jan 202211:07 amRNSNet Asset Value(s)
7th Jan 202211:02 amRNSNet Asset Value(s)
6th Jan 202211:12 amRNSNet Asset Value(s)
5th Jan 202211:14 amRNSNet Asset Value(s)
4th Jan 20222:56 pmRNSTotal Voting Rights
4th Jan 20221:21 pmRNSGearing Announcement
4th Jan 20221:18 pmRNSNet Asset Value(s)
31st Dec 202111:46 amRNSNet Asset Value(s)
30th Dec 202111:04 amRNSNet Asset Value(s)
29th Dec 20215:21 pmRNSTransaction in Own Shares
29th Dec 202112:14 pmRNSGearing Announcement
29th Dec 202111:16 amRNSNet Asset Value(s)
24th Dec 202111:31 amRNSNet Asset Value(s)
23rd Dec 202110:44 amRNSNet Asset Value(s)
22nd Dec 202110:43 amRNSNet Asset Value(s)
22nd Dec 202110:13 amRNSDirectorate Change
21st Dec 202111:20 amRNSNet Asset Value(s)
20th Dec 20214:34 pmRNSPublication of Circular
20th Dec 202111:18 amRNSNet Asset Value(s)
20th Dec 202110:54 amRNSGearing Announcement
17th Dec 202111:27 amRNSNet Asset Value(s)
16th Dec 202111:09 amRNSNet Asset Value(s)
15th Dec 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.